🇺🇸 FDA
Patent

US 10828265

Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery

granted A61KA61K31/138A61K31/194

Quick answer

US patent 10828265 (Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery) held by The Regents of the University of California expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/138, A61K31/194, A61K47/10, A61K47/12